News in the Life Sciences Industry

ABBOTT PARK, Ill., Nov. 13, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that Miles D. White will be stepping down as Chief Executive Officer on March 31, 2020, after a remarkable 21-year tenure, the second longest for a non-founder in today's S&P 100. He will remain Executive... Read more ››

GATINEAU, Quebec, Nov. 13, 2019 /PRNewswire/ -- Macadamian was recognized as a market leader in an international cross-sector competitive assessment of Pharma, Biotech, Medtech, and ICT companies. The report looked at companies that embarked on disruptive digitalization strategies in healthcare... Read more ››

LAINATE, Italy, Nov. 13, 2019 /PRNewswire/ -- Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company focused on developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today that... Read more ››

SAN FRANCISCO and SEATTLE, Nov. 12, 2019 /PRNewswire/ -- With a $106 million gift from the Weill Family Foundation, UC Berkeley (Berkeley), UC San Francisco (UCSF), and the University of Washington (the UW) have launched the Weill Neurohub, an innovative research network that will forge and nurture... Read more ››

-- License to accelerate research, enable testing and development of new drugs

Strategic move gives Telemis a significant presence in the German market and an enhanced product and service offering

New Product Offers Medical Device Manufacturers High Clarity Peelable Heat Shrink in Ratios Up To 2:1

BERLIN and TORONTO, Nov. 11, 2019 /PRNewswire/ -- ATAI Life Sciences AG, a global biotech platform that envisions an end to... Read more ››

DOHA, Qatar, Nov. 9, 2019 /PRNewswire/ -- After months spent building, testing, and developing innovative technology, Youssef El Azouzi was announced the Arab world's top innovator in the Grand Final of Stars of Science Season 11. Through a combination of technical expertise and a keen... Read more ››

BRUSSELS, Nov. 8, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced important new rheumatology data being presented on CIMZIA® (certolizumab pegol) and investigational molecules bimekizumab and dapirolizumab pegol at the 2019 American College of Rheumatology and the... Read more ››

Not intended for US, Canada and UK-based media

Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth

SINGAPORE, Nov. 8, 2019 /PRNewswire/ -- As populations continue to grow, medical institutions around the world are faced with the challenge of efficiently managing resources to meet the growing demand for medical care and treatment. By recently partnering with pressure and vacuum experts like... Read more ››